AU2002349260A8 - Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof - Google Patents

Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof

Info

Publication number
AU2002349260A8
AU2002349260A8 AU2002349260A AU2002349260A AU2002349260A8 AU 2002349260 A8 AU2002349260 A8 AU 2002349260A8 AU 2002349260 A AU2002349260 A AU 2002349260A AU 2002349260 A AU2002349260 A AU 2002349260A AU 2002349260 A8 AU2002349260 A8 AU 2002349260A8
Authority
AU
Australia
Prior art keywords
cancer
prevention
treatment
pharmaceutical composition
cell differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002349260A
Other versions
AU2002349260A1 (en
Inventor
Ming-Cheng Liau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Grand Co Ltd
Original Assignee
Bio Grand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Grand Co Ltd filed Critical Bio Grand Co Ltd
Priority claimed from PCT/CN2002/000831 external-priority patent/WO2004045490A2/en
Publication of AU2002349260A1 publication Critical patent/AU2002349260A1/en
Publication of AU2002349260A8 publication Critical patent/AU2002349260A8/en
Abandoned legal-status Critical Current

Links

AU2002349260A 2002-11-20 2002-11-20 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof Abandoned AU2002349260A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2002/000831 WO2004045490A2 (en) 2002-11-14 2002-11-20 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof

Publications (2)

Publication Number Publication Date
AU2002349260A1 AU2002349260A1 (en) 2004-06-15
AU2002349260A8 true AU2002349260A8 (en) 2004-06-15

Family

ID=34318851

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349260A Abandoned AU2002349260A1 (en) 2002-11-20 2002-11-20 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof

Country Status (1)

Country Link
AU (1) AU2002349260A1 (en)

Also Published As

Publication number Publication date
AU2002349260A1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
TWI346558B (en) Pharmaceutical composition for chronic treatment of inflammation and use thereof
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
IL230815A0 (en) Diketopiperazine compounds and pharmaceutical compositions comprising the same for treating of t-cell mediated diseases
HUP0600781A2 (en) Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing them
AU2003216586A8 (en) Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
HUP0400119A3 (en) Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
IL172704A (en) Pharmaceutical composition comprising a salinosporamide compound and use thereof in the manufacture of a medicament for treating cancer
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
GB0615918D0 (en) Composition and its therapeutic use
IL164470A (en) Pharmaceutical composition comprising arsenite for the treatment of solid malignancies
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
HUP0103017A3 (en) Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
AU2003245858A8 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
EP1551452A4 (en) Compositions and methods for therapeutic treatment
IL152832A0 (en) Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
AU2002349260A8 (en) Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
EP1666046A4 (en) Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
EP1551456A4 (en) Pharmaceutical composition for prevention and treatment of kidney diseases
ZA200209501B (en) Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase